Diversify Advisory Services LLC Makes New $5.82 Million Investment in Stryker Corporation $SYK

Key Points

• Diversify Advisory Services acquired 17,275 Stryker shares worth approximately $5.82 million during the second quarter. Institutional investors collectively own 77.09% of the company.
• Stryker reported quarterly EPS of $3.69, beating estimates by $0.20, while revenue rose 9.4% year over year to $6.59 billion. The company maintained fiscal 2026 EPS guidance of $14.95–$15.10.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $386.28, while Stryker pays a quarterly dividend of $0.88 per share. Recent insider activity was predominantly selling, including a $96.8 million sale by director Ronda E. Stryker.

Diversify Advisory Services LLC acquired a new position in Stryker Corporation (NYSE:SYK - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 17,275 shares of the medical technology company's stock, valued at approximately $5,817,000.

Other institutional investors also recently bought and sold shares of the company. Gables Capital Management Inc. bought a new stake in Stryker in the second quarter valued at approximately $25,000. Godfrey Financial Associates Inc. bought a new stake in Stryker during the 4th quarter valued at $26,000. Sankala Group LLC purchased a new stake in Stryker during the 4th quarter valued at $26,000. United Financial Planning Group LLC purchased a new stake in Stryker during the 3rd quarter valued at $27,000. Finally, Atlas Capital Advisors Inc. bought a new stake in Stryker in the 4th quarter worth $27,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Stryker Stock Performance

Shares of SYK opened at $331.96 on Wednesday. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The company has a 50-day simple moving average of $325.56 and a two-hundred day simple moving average of $333.05. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The firm has a market capitalization of $127.33 billion, a PE ratio of 34.40, a price-to-earnings-growth ratio of 2.16 and a beta of 0.76.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company had revenue of $6.59 billion during the quarter, compared to analysts' expectations of $6.58 billion. During the same quarter last year, the business posted $3.13 EPS. The firm's revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts anticipate that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's payout ratio is 36.48%.

Insider Transactions at Stryker

In related news, VP Robert S. Fletcher sold 4,544 shares of the business's stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president owned 10,582 shares of the company's stock, valued at $3,247,298.34. The trade was a 30.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the company's stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. This trade represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 315,370 shares of company stock valued at $98,463,501 in the last three months. 4.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Leerink Partners dropped their target price on shares of Stryker from $410.00 to $407.00 and set an "outperform" rating for the company in a report on Friday, June 5th. Evercore set a $350.00 price target on Stryker in a report on Monday, July 6th. Raymond James Financial set a $370.00 price target on Stryker in a research report on Friday, July 31st. Weiss Ratings reissued a "hold (c)" rating on shares of Stryker in a research note on Friday, July 31st. Finally, The Goldman Sachs Group restated a "neutral" rating and set a $361.00 target price on shares of Stryker in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $386.28.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source